Abbott Laboratories News

Barclays: Maintaining the Abbott Laboratories (ABT.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $141.00 to $140.00.

Zhitong FinanceApr 22 20:40

Abbott Laboratories Analyst Ratings

BenzingaApr 22 20:35

Abbott Laboratories Analyst Ratings

BenzingaApr 18 23:52

RBC Capital Maintains Outperform on Abbott Laboratories, Lowers Price Target to $125

BenzingaApr 18 23:54

Abbott Laboratories Analyst Ratings

BenzingaApr 5 00:17

Evercore ISI Group Maintains Outperform on Abbott Laboratories, Raises Price Target to $125

BenzingaApr 5 00:18

Abbott Laboratories Analyst Ratings

BenzingaApr 3 23:31

Abbott Laboratories Analyst Ratings

BenzingaFeb 14 22:48

Edwards Stock Jumps 8% on FDA Approval, Wells Fargo Upgrade

Seeking AlphaFeb 3 01:20

Barclays Raises Abbott Laboratories' Price Target to $141 From $133, Keeps Overweight Rating

MT NewswiresJan 27 04:04

Barclays: Maintaining Abbott Laboratories' (ABT.US) holdings increase rating, and the target price was adjusted from $133.00 to $141.00.

Zhitong FinanceJan 27 02:31

Abbott Laboratories Analyst Ratings

BenzingaJan 27 02:20

JPMorgan Raises Abbott Laboratories Price Target to $125 From $122, Maintains Overweight Rating

MT NewswiresJan 25 20:53

RBC Capital Sticks to Its Buy Rating for Abbott Labs (ABT)

TipRanksJan 25 20:26

Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $127

BenzingaJan 25 20:26

Abbott Laboratories Analyst Ratings

BenzingaJan 25 20:24

UBS Raises Abbott Laboratories Price Target to $136 From $122, Maintains Buy Rating

MT NewswiresJan 23 00:10

RBC Capital Maintains Outperform on Abbott Laboratories, Raises Price Target to $128

BenzingaJan 12 00:08

Abbott Laboratories Analyst Ratings

BenzingaJan 12 00:07

Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $124

BenzingaJan 4 00:24